
|Articles|April 1, 2016
- Pharmaceutical Executive-04-01-2016
- Volume 36
- Issue 4
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Closing the Gaps in Drug Chain of Custodyalmost 10 years ago
Data Unleashed: Cooperation Among Competitorsalmost 10 years ago
Raising the Stakes On Value-Based Pricingalmost 10 years ago
The Diversity Dearth in Pharmaalmost 10 years ago
Information in Action: A Conversation with Barbara Lopez Kunzalmost 10 years ago
R&D Model Mixes Compassion, Calculationalmost 10 years ago
Pressure Builds to Revamp Off-Label Marketing Rulesalmost 10 years ago
Drug Compounding: A Cause and Cure for High Drug Prices?almost 10 years ago
The Odd Couplealmost 10 years ago
Country Report: EgyptNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff
4
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
5



